SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 4.36 |
Enterprise Value ($M) | 3.16 |
Book Value ($M) | 9.54 |
Book Value / Share | 2.95 |
Price / Book | 0.46 |
NCAV ($M) | 7.37 |
NCAV / Share | 2.28 |
Price / NCAV | 0.59 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.99 |
Return on Assets (ROA) | -0.57 |
Return on Equity (ROE) | -0.59 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 11.36 |
Current Ratio | 11.36 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 8.19 |
Assets | 10.35 |
Liabilities | 0.82 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -9.93 |
Net Income | -9.29 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -8.21 |
Cash from Investing | 3.51 |
Cash from Financing | 0.57 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
367 | 3,230 | 11.36 | |
3,193 | 12,762 | 25.02 | |
6,046 | 16,731 | 36.14 | |
780 | 13,560 | 5.75 | |
6,634 | 16,060 | 41.31 | |
(click for more detail) |
Similar Companies | |
---|---|
APRE – Aprea Therapeutics, Inc. | APTO – Aptose Biosciences Inc. |
APVO – Aptevo Therapeutics Inc. | ASNS – Actelis Networks, Inc. |
ASRT – Assertio Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io